Overview
Dr. Athe Tsibris completed his medical degree at the University of South Florida, his Medicine residency and Chief Residency at Northwestern University Feinberg School of Medicine, and then entered the combined Infectious Disease Fellowship at Massachusetts General Hospital and Brigham and Women’s Hospital in Boston, Massachusetts.He performed his postdoctoral work in the laboratory of Daniel Kuritzkes, MD, where he focused on the mechanisms of HIV-1 escape from CCR5 antagonism. Dr. Tsibris is now an Assistant Professor at Harvard Medical School who works as an Infectious Disease physician scientist and runs an active molecular virology lab that studies the fundamental biology and dynamics of HIV reservoirs. Athe and his lab leverage innovative experimental approaches to better understand HIV-1 and HIV-2 persistence and use these insights to design and test novel strategies to eliminate latently HIV-infected cells. Currently, Athe chairs a national study of a first-in-human trispecific broadly neutralizing antibody against HIV. Locally, Athe heads the HIV Eradication and Latency (HEAL) cohort and chairs Brigham’s COVID Implementation Committee, a group that facilitates the efficient and fair enrollment of Brigham inpatients into open and enrolling COVID-related clinical trials. He is committed, through work with the Harvard Center for AIDS Research, to the mentoring and career development of the next generation of HIV scientists.
Dr. Tsibris is highly rated in 1 condition, according to our data. His top areas of expertise are HIV/AIDS and Sepsis.
His clinical research consists of co-authoring 32 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Graduate Institution
Residency
Specialties
Licenses
Board Certifications
Fellowships
Hospital Affiliations
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- HMO
- INDEMNITY
- POS
- PPO
- OTHER MANAGED MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- PPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
75 Francis St, Boston, MA 02115
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Fenway Community Health Center Inc.
Kenneth Mayer is an Infectious Disease provider in Boston, Massachusetts. Dr. Mayer is highly rated in 10 conditions, according to our data. His top areas of expertise are HIV/AIDS, Syphilis, Gonorrhea, Chlamydia, and Tissue Biopsy.
Brigham And Womens Physicians Organization Inc
Dr. Paul E. Sax is Clinical Director of the Division of Infectious Diseases at Brigham and Women's Hospital (BWH), where he holds the Bruce and Robert Beal Distinguished Chair, and Professor of Medicine at Harvard Medical School. Dr. Sax received his MD from Harvard Medical School, did his residency in Internal Medicine at BWH, then fellowship in Infectious Diseases at Massachusetts General Hospital.He is Editor-in-Chief of Open Forum Infectious Diseases, is Section Editor of HIV/AIDS in UpToDate, on the Editorial Board of NEJM Journal Watch Infectious Diseases (where he writes the HIV and ID Observations blog), and on the editorial advisory board of Medscape HIV/AIDS. Dr. Sax is the Associate Program Director for the Mass General Brigham fellowship in Infectious Diseases, is on the core faculty of the International Antiviral Society – USA, and teaches regularly on HIV and infectious diseases locally, nationally, and internationally. In addition to his clinical practice and teaching, Dr. Sax’s ongoing areas of research include clinical trials of antiretroviral therapies, cost-effectiveness of management strategies for HIV, and toxicity of antiretroviral therapy. He is presently the principal investigator at the BWH AIDS Clinical Trials Unit, and is a member of the Cost-Effectiveness of Preventing AIDS Complications (CEPAC) Research Group. Dr. Sax is highly rated in 7 conditions, according to our data. His top areas of expertise are HIV/AIDS, Nontuberculous Mycobacterial Lung Disease, Myelitis, and AIDS Dementia Complex.
Brigham And Women's Hospital, Division Of Infectious Diseases
Daniel R. Kuritzkes, MD received his BS and MS degrees in Molecular Biophysics and Biochemistry from Yale University, and his MD from Harvard Medical School. He completed his clinical and research training in internal medicine and infectious diseases at Massachusetts General Hospital and was a visiting scientist at the Whitehead Institute for Biomedical Research before joining the faculty at the University of Colorado Health Sciences Center. Dr. Kuritzkes returned to Harvard Medical School in 2002, where he is now the Harriet Ryan Albee Professor of Medicine and Chief, Division of Infectious Diseases at Brigham and Women’s Hospital. Dr. Kuritzkes has published extensively on antiretroviral therapy and drug resistance in HIV-1 infection. He has chaired several multicenter studies of HIV therapy and previously chaired the AIDS Clinical Trials Group. He has served on numerous NIH committees, including as a member of the NIH Office of AIDS Research Advisory Council. He is a former member of the Department of Health and Human Services panel on guidelines for antiretroviral therapy and a past Chair of the HIV Medicine Association Board of Directors. He has been a member of several editorial boards, and serves as an Associate Editor of the Journal of Infectious Diseases. His research interests focus on HIV therapeutics, antiretroviral drug resistance, HIV eradication and more recently, COVID-19. Dr. Kuritzkes is highly rated in 5 conditions, according to our data. His top areas of expertise are HIV/AIDS, Myelitis, AIDS Dementia Complex, and AIDS Dysmorphic Syndrome.
Frequently Asked Questions about Dr. Athe M. Tsibris
How do I make an appointment with Dr. Athe M. Tsibris?
You can book an appointment with Dr. Athe M. Tsibris by calling their office at 617-732-5500. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Athe M. Tsibris a top-rated expert for HIV/AIDS?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Athe M. Tsibris is classified as an Advanced expert for HIV/AIDS, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Athe M. Tsibris specialize in?
While Dr. Athe M. Tsibris is a Infectious Disease, they have specific expertise in HIV/AIDS, Sepsis. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Infectious Disease.
Does Dr. Athe M. Tsibris participate in research or clinical trials?
Yes. Dr. Athe M. Tsibris has published 32 articles and abstracts on conditions like HIV/AIDS. You can view a list of Dr. Athe M. Tsibris's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Athe M. Tsibris accept my insurance?
Dr. Athe M. Tsibris accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 617-732-5500 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- HIV/AIDSDr. Tsibris isAdvanced. Learn about HIV/AIDS.
- Experienced
- SepsisDr. Tsibris isExperienced. Learn about Sepsis.